Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Endocannabinoids and neurodegenerative diseases.
Distraction adds to the cognitive burden in multiple sclerosis.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.
Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
The benefits of exercise training in multiple sclerosis.
Update on biomarkers in neuromyelitis optica.
RNF and Betaseron® Tolerability Study (REFORMS)
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
The histaminergic network in the brain: basic organization and role in disease.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
Impact of diagnosis and early treatment on the course of multiple sclerosis.
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »